Potrero Medical announced that Steve Okland will join Potrero Medical as Chief Commercial Officer.
| HAYWARD, Calif., Oct. 13, 2021 /PRNewswire/ --Potrero Medical, Inc. innovator of the Accuryn Monitoring System, a sensory integrated foley catheter that provides real-time, actionable information to health care providers so they can take steps to prevent the progression of critical conditions such as acute kidney injury (AKI), announced that Steve Okland will join Potrero Medical as Chief Commercial Officer. “We are excited to welcome Steve to Potrero as we look forward to continuing to prepare Potrero for increasing growth to deliver our life-changing technology to patients, healthcare professionals and hospitals,” said Chief Executive Officer Joe Urban.
“I look forward to joining Potrero, and delivering new ways to monitor the kidney and manage fluid in acute patients.” “Steve’s proven track record as a catalyst in driving market adoption of new technologies along with experience as a chief commercial officer is what is required for Potrero to continue our growth strategy,” said Urban. “I look forward to working closely with Steve as member of the executive team as we continue to execute our mission while offering solutions to save health systems money.” “The people at Potrero share a commitment to pushing the boundaries and developing breakthrough technologies,” said Mr. Oakland. “I look forward to joining the team to build a commercial organization focused on bringing important new ways to monitor the kidney and manage fluid in acute patients.” Mr. Okland has served as the Chief Commercial Officer and on the senior leadership teams for Second Sight Medical Products and DryShield. He has an undergraduate degree from the University of Wisconsin in Finance and Marketing, and an MBA from Texas Christian University. About Potrero Medical Media Relations Contact:
SOURCE Potrero Medical, Inc. |
View original content to download multimedia:
